Richard Paxman - Paxman AB CEO Director
| PAX Stock | SEK 63.00 0.40 0.64% |
Insider
Richard Paxman is CEO Director of Paxman AB
| Age | 40 |
| Phone | 46 7 09 43 96 71 |
| Web | https://paxmanscalpcooling.com |
Paxman AB Management Efficiency
The company has return on total asset (ROA) of (0.0412) % which means that it has lost $0.0412 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0254) %, meaning that it generated substantial loss on money invested by shareholders. Paxman AB's management efficiency ratios could be used to measure how well Paxman AB manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Itedale Redwan | BICO Group AB | N/A | |
| Kristoffer Nordstrom | Xvivo Perfusion AB | 38 | |
| Henrik Ljung | SpectraCure AB | 65 | |
| Johan Folkunger | SpectraCure AB | 55 | |
| Hector Martinez | BICO Group AB | 38 | |
| Henrik Storm | Mentice AB | 51 | |
| Kristina Holst | SpectraCure AB | N/A | |
| Erica Bell | BICO Group AB | 50 | |
| Johanna Tulkki | Senzime AB | 53 | |
| Gran Malmberg | Mentice AB | 64 | |
| Jason Clifton | BICO Group AB | N/A | |
| Lotta Bus | BICO Group AB | 53 | |
| Andreas MD | Xvivo Perfusion AB | 46 | |
| Benjamin Speich | Mentice AB | 41 | |
| Erik Gatenholm | BICO Group AB | 34 | |
| Jaya Tiwari | Xvivo Perfusion AB | N/A | |
| Pontus Appelqvist | Mentice AB | N/A | |
| Johannes Swartling | SpectraCure AB | 51 | |
| Stacy Hammar | Mentice AB | N/A | |
| Katrin Gisselfalt | Xvivo Perfusion AB | 54 | |
| Mirjam Johansson | SpectraCure AB | N/A | |
Management Performance
| Return On Equity | -0.0254 | |||
| Return On Asset | -0.0412 |
Paxman AB Leadership Team
Elected by the shareholders, the Paxman AB's board of directors comprises two types of representatives: Paxman AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Paxman. The board's role is to monitor Paxman AB's management team and ensure that shareholders' interests are well served. Paxman AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Paxman AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Patrick Burke, Head Operations | ||
| Emma Thornhill, Head Fin | ||
| Emelie Gustafsson, Chief Officer | ||
| Claire Paxman, Director Initiatives | ||
| Anna Parker, Head Sales | ||
| Liza Hirst, EA HR | ||
| Stuart Rowling, Head Sales | ||
| Richard Paxman, CEO Director | ||
| Susy Brown, Head Marketing | ||
| Alexandra Sheldrake, Head Affairs |
Paxman Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Paxman AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0254 | |||
| Return On Asset | -0.0412 | |||
| Profit Margin | (0.02) % | |||
| Operating Margin | (0.07) % | |||
| Current Valuation | 788.68 M | |||
| Shares Outstanding | 19.01 M | |||
| Shares Owned By Insiders | 64.44 % | |||
| Shares Owned By Institutions | 7.74 % | |||
| Price To Book | 6.60 X | |||
| Price To Sales | 5.86 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Paxman Stock Analysis
When running Paxman AB's price analysis, check to measure Paxman AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Paxman AB is operating at the current time. Most of Paxman AB's value examination focuses on studying past and present price action to predict the probability of Paxman AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Paxman AB's price. Additionally, you may evaluate how the addition of Paxman AB to your portfolios can decrease your overall portfolio volatility.